Europe
DCprime Initiates Research Collaboration with the University Medical Center of Groningen on Relapse Vaccine Approach for Ovarian Cancer
Proceeds to fund multi-centre study of STAR Mapping to improve outcomes of persistent Atrial Fibrillation treatment
Secarna Pharmaceuticals announced that the Company has entered into an research agreement with a global pharmaceutical company to support research and discovery in the field of oncology.
EveliQure Biotechnologies announces the award of a grant from Horizon2020 - the European Union´s Research and Innovation programme - that supports first-in-man studies of its proprietary ShigETEC vaccine.
BerGenBio ASA announces that Richard Godfrey, BergenBio’s chief executive officer, will present at the H.C. Wainwright 21st Annual Global Life Sciences Conference today, September 10, 2019.
Oncimmune Holdings plc welcomes the presentation of data by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT® Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.
ProBioGen AG announced the closing of a license agreement with Bayer AG for the GlymaxX® Technology.
Bioinformatic software is the basis for development in the automated relevance-based detection of blood-stream infections
Pneumagen Ltd announced in vivo data on its lead product, Neumifil™, generated from its proprietary GlycoTarge platform.
Futura Medical plc is pleased to announce a joint venture collaboration with CBDerma Technology Limited to explore the application of Futura’s advanced proprietary transdermal drug delivery technology, DermaSys® for delivery of Cannabidiol.
PRESS RELEASES